Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantationMauro Di Ianni|Blood|2011Cited by 1k
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)Massimo Breccia, Filíppo Gherlinzoni, Francesco Mendicino et al.|Cancer|2025Cited by 10